MAPK8 and obesity due to melanocortin 4 receptor deficiency: Thus, JNK1 inhibition has proven to exert significant beneficial effects, such as neuroprotection, neuroinflammatory modulation, and prevention of type 2 diabetes and obesity [133,134].